CTRI Number |
CTRI/2025/05/086297 [Registered on: 05/05/2025] Trial Registered Prospectively |
Last Modified On: |
18/04/2025 |
Post Graduate Thesis |
No |
Type of Trial |
PMS |
Type of Study
|
Other (Specify) [Cosmetics] |
Study Design |
Single Arm Study |
Public Title of Study
|
Eye Stinging Potential of Silphion S-Face Wash E |
Scientific Title of Study
|
A Clinical Study to Evaluate the Eye Stinging Potential of Silphion S-Face Wash E on Healthy Human Volunteers |
Trial Acronym |
NIL |
Secondary IDs if Any
|
Secondary ID |
Identifier |
CCFT579 Version 1.0 dated 17 Mar 2025 |
Protocol Number |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Robin Chugh |
Designation |
Principal Investigator |
Affiliation |
CCFT Laboratories |
Address |
1st Floor room 3, Skin testing lab , CCFT laboratories, AR multispecialty hospital and research center, Delhi Road
Meerut UTTAR PRADESH 250002 India |
Phone |
9027285265 |
Fax |
|
Email |
robinderm25@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Puneet Mittal |
Designation |
Clinical Research Consultant |
Affiliation |
CCFT Laboratories |
Address |
CCFT Laboratories, Mittal Group Building, 121-B Mansarovar Industrial Estate, Panchli, Baghpat Road
Meerut UTTAR PRADESH 250005 India |
Phone |
8937015757 |
Fax |
|
Email |
puneetmittal@mgcts.org |
|
Details of Contact Person Public Query
|
Name |
Puneet Mittal |
Designation |
Clinical Research Consultant |
Affiliation |
CCFT Laboratories |
Address |
CCFT Laboratories, Mittal Group Building, 121-B Mansarovar Industrial Estate, Panchli, Baghpat Road
UTTAR PRADESH 250005 India |
Phone |
8937015757 |
Fax |
|
Email |
puneetmittal@mgcts.org |
|
Source of Monetary or Material Support
|
CCFT Laboratories, Mittal Group Building, 121-B Mansarovar Industrial Estate, Panchli, Baghpat Road, UTTAR PRADESH, 250005-India |
Silphion Research Private Limited, 4TH FLOOR, Old No, 95/44, First Main Road, Gandhi Nagar, Adyar, Chennai City Corporation, Chennai – 600 020. |
|
Primary Sponsor
|
Name |
Silphion Research Private Limited |
Address |
4
TH FLOOR, Old No, 95/44, First Main Road, Gandhi Nagar, Adyar, Chennai City Corporation, Chennai – 600 020. |
Type of Sponsor |
Pharmaceutical industry-Indian |
|
Details of Secondary Sponsor
|
Name |
Address |
Not Applicable |
Not Applicable |
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Ishika Gandhi |
CCFT laboratories |
1st Floor room 3, Skin testing lab , CCFT laboratories, AR multispecialty hospital and research center, Delhi Road Meerut UTTAR PRADESH |
7455086734
ishika02gandhi@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
ARMHRC Institutional Ethics Committee |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Healthy Human Volunteers |
Not Applicable |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Comparator Agent |
Not Applicable |
Not Applicable |
Intervention |
Test product: Silphion S-Face Wash E |
Dose: Approx 5 microliter Route: in eyes(on the lower sac) Frequency: Once Duration: 5 mins |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
65.00 Year(s) |
Gender |
Both |
Details |
1. Individual should have ITA angle in the range of 18 t0 40, 41 to 55, and greater than 56
2. Individuals free of any dermatological or systemic disorder which would interfere with the results, at the discretion of the investigator.
3. Individuals who have completed a preliminary medical history evaluation.
4. Individuals who have read, understood and signed an informed consent document relating to the specific study to which they are subscribing.
5. Individuals with no known abnormal response to sunlight. |
|
ExclusionCriteria |
Details |
1.Individuals taking medication which in the opinion of the investigator would mask or interfere with the results.
2.Individuals with chronic skin allergies.
3.Individuals with suntan or sunburn.
4.Individuals with abnormal reaction to the sun.
5.Pregnant or lactating females.
6.Subjects accustomed to using sun beds.
7.Subjects who have participated in an SPF study within the last two months. |
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Open Label |
Primary Outcome
|
Outcome |
TimePoints |
1.Change in conjunctival inflammation
2. Change in cornea and iris inflammation
3. Change in Subject Discomfort |
0min, 1min, 5min |
|
Secondary Outcome
|
Outcome |
TimePoints |
Not Applicable |
Not Applicable |
|
Target Sample Size
|
Total Sample Size="32" Sample Size from India="32"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Post Marketing Surveillance |
Date of First Enrollment (India)
|
15/05/2025 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="0" Months="0" Days="2" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
N/A |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
single arm clinical study. 5 μL of the appropriate test should be instilled into the lower conjunctival sac of one eye, and another eye should be instilled with Normal Saline as Negative control. No Positive control to be taken. Assessment would be done as 5-point scale for the below attributes after 1 min/2 min/5 min. 1. Subjective discomfort, Score 0: No discomfort felt Score 1: Faint, barely perceptible discomfort Score 2: Mild, low intensity discomfort that does not prevent the subject from opening lids Score 3: Moderately intense discomfort that interferes with but does not prevent lid opening Score 4: Severe, very intense discomfort that makes voluntary lid opening difficult, requires force to pull lids apart, and results in the subject requesting washout of test article 2. Objective lacrimation, Score 0: No tearing or lid wetness above normal Score 1: Noticeable increase in moistness of lid edges - no frank tearing Score 2: Frank tearing - meager flow Score 3: Frank tearing - moderate flow Score 4: Frank tearing - copious flow 3. Objective conjunctival inflammation, Score 0: Inflammatory changes absent Score 1: Capillaries slightly more prominent than they were at time of baseline examination Score 2: Capillaries very prominent plus some diffuse conjunctival reddening Score 3: Vessels very prominent plus diffuse and confluent intense redness Score 4: Beefy redness and everted lids 4. Objective cornea and iris inflammation Score 0: No effect detected with use of slit lamp Score 1: Barely perceptible clouding or pitting of cornea or thickening of iris detected via slit lamp Score 2: Faint clouding or pitting of cornea and/or thickening of the iris Score 3: Moderate clouding or pitting of cornea and/or thickening of the iris Score 4: Intense clouding orpitting of cornea and/or thickening of the iris A follow-up visit is done after 24 hours to assess any adverse effect after the Product application |